Fangxin Hong
Fangxin Hong
Sr. Research Scientist, Dana-Farber Cancer Institute, Harvard School of Public Health
Verified email at jimmy.harvard.edu
Title
Cited by
Cited by
Year
Rapid synthesis of auxin via a new tryptophan-dependent pathway is required for shade avoidance in plants
Y Tao, JL Ferrer, K Ljung, F Pojer, F Hong, JA Long, L Li, JE Moreno, ...
Cell 133 (1), 164-176, 2008
9922008
Different plant hormones regulate similar processes through largely nonoverlapping transcriptional responses
JL Nemhauser, F Hong, J Chory
Cell 126 (3), 467-475, 2006
9092006
Signals from chloroplasts converge to regulate nuclear gene expression
S Koussevitzky, A Nott, TC Mockler, F Hong, G Sachetto-Martins, M Surpin, ...
Science 316 (5825), 715-719, 2007
8392007
RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis
F Hong, R Breitling, CW McEntee, BS Wittner, JL Nemhauser, J Chory
Bioinformatics 22 (22), 2825-2827, 2006
7612006
Highly potent, selective, and low cost bis-tetrahydroaminacrine inhibitors of acetylcholinesterase: steps toward novel drugs for treating Alzheimer's disease
YP Pang, P Quiram, T Jelacic, F Hong, S Brimijoin
Journal of Biological Chemistry 271 (39), 23646-23649, 1996
4921996
Network discovery pipeline elucidates conserved time-of-day–specific cis-regulatory modules
TP Michael, TC Mockler, G Breton, C McEntee, A Byer, JD Trout, ...
PLoS genetics 4 (2), e14, 2008
4812008
Molecular mechanisms of steroid hormone signaling in plants
G Vert, JL Nemhauser, N Geldner, F Hong, J Chory
Annu. Rev. Cell Dev. Biol. 21, 177-201, 2005
4262005
A comparison of meta-analysis methods for detecting differentially expressed genes in microarray experiments
F Hong, R Breitling
Bioinformatics 24 (3), 374-382, 2008
2762008
Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated …
LI Gordon, F Hong, RI Fisher, NL Bartlett, JM Connors, RD Gascoyne, ...
Journal of Clinical Oncology 31 (6), 684, 2013
2732013
Rates of peripheral arterial occlusive disease in patients with chronic myeloid leukemia in the chronic phase treated with imatinib, nilotinib, or non-tyrosine kinase therapy …
FJ Giles, MJ Mauro, F Hong, CE Ortmann, C McNeill, RC Woodman, ...
Leukemia 27 (6), 1310-1315, 2013
2172013
Tumor-associated macrophages predict inferior outcomes in classic Hodgkin lymphoma: a correlative study from the E2496 Intergroup trial
KL Tan, DW Scott, F Hong, BS Kahl, RI Fisher, NL Bartlett, RH Advani, ...
Blood, The Journal of the American Society of Hematology 120 (16), 3280-3287, 2012
2092012
Rituximab extended schedule or re-treatment trial for low–tumor burden follicular lymphoma: Eastern Cooperative Oncology Group Protocol E4402
BS Kahl, F Hong, ME Williams, RD Gascoyne, LI Wagner, JC Krauss, ...
Journal of Clinical Oncology 32 (28), 3096, 2014
1812014
Gene expression–based model using formalin-fixed paraffin-embedded biopsies predicts overall survival in advanced-stage classical Hodgkin lymphoma
DW Scott, FC Chan, F Hong, S Rogic, KL Tan, B Meissner, S Ben-Neriah, ...
Journal of Clinical Oncology 31 (6), 692, 2013
1662013
Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial
DL Berry, F Hong, B Halpenny, AH Partridge, JR Fann, S Wolpin, ...
Journal of Clinical Oncology 32 (3), 199, 2014
1622014
Phase II trial of weekly bortezomib in combination with rituximab in relapsed or relapsed and refractory Waldenström macroglobulinemia
IM Ghobrial, F Hong, S Padmanabhan, A Badros, M Rourke, R Leduc, ...
Journal of Clinical Oncology 28 (8), 1422, 2010
1542010
Clinical and translational studies of a phase II trial of the novel oral Akt inhibitor perifosine in relapsed or relapsed/refractory Waldenström's macroglobulinemia
IM Ghobrial, A Roccaro, F Hong, E Weller, N Rubin, R Leduc, M Rourke, ...
Clinical Cancer Research 16 (3), 1033-1041, 2010
1312010
Rational design of alkylene-linked bis-pyridiniumaldoximes as improved acetylcholinesterase reactivators
YP Pang, TM Kollmeyer, F Hong, JC Lee, PI Hammond, SP Haugabouk, ...
Chemistry & biology 10 (6), 491-502, 2003
1312003
Subset of heat-shock transcription factors required for the early response of Arabidopsis to excess light
HS Jung, PA Crisp, GM Estavillo, B Cole, F Hong, TC Mockler, BJ Pogson, ...
Proceedings of the National Academy of Sciences 110 (35), 14474-14479, 2013
1232013
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial
JA Kanakry, H Li, LL Gellert, MV Lemas, W Hsieh, F Hong, KL Tan, ...
Blood, The Journal of the American Society of Hematology 121 (18), 3547-3553, 2013
1222013
Synthesis and SAR of 2-arylbenzoxazoles, benzothiazoles and benzimidazoles as inhibitors of lysophosphatidic acid acyltransferase-β
B Gong, F Hong, C Kohm, L Bonham, P Klein
Bioorganic & medicinal chemistry letters 14 (6), 1455-1459, 2004
1122004
The system can't perform the operation now. Try again later.
Articles 1–20